Panacea’s Post

#rarediseaseday Today, at gMendel®, we all show our stripes to celebrate the Rare Disease Day and raise awareness for diversity, equity, and inclusion in social opportunities, healthcare, and access to diagnosis and treatments for those affected by rare diseases, as well as their families and loved ones. The zebra's stripes, an official emblem of rare diseases, epitomize uniqueness and distinction. In a similar way, each of us bears our own "stripes"—those individual traits and characteristics that distinguish us as unique individuals. 350 million people worldwide live with a rare disease. Among them, 50% are children, with 30% of them not making it to their 5th birthday. Furthermore, rare diseases account for 35% of deaths in the first year of life, highlighting the urgent need for awareness and action. Early diagnosis and therapeutic interventions can enable people affected by rare diseases to lead productive and fulfilling lives. At gMendel®, we have developed an AI-powered, vertically integrated IVD certified technology for accurate, fast, and affordable diagnosis of genetic disorders. Our ambition is to democratise diagnosis of genetic disorders and contribute to the development of more treatments available for the many families living with the burden of rare diseases. #rarediseaseday2024 #orphandrugs #DigitalHealth #healthcare #globalhealth #business #innovation #healthtech #healthinnovation #genetics #genomics #rarediseases #geneticdisorders #genetictesting #screening #diagnostics #artificialintelligence #machinelearning #companiondiagnostics #VC #venturecapital Marimekko Netcetera National Organization for Rare Disorders EURORDIS-Rare Diseases Europe

In our recent podcast session- HealthSpeak with MDForLives, we invited Nick Fontanella, who shared his views on how genetic variations influence medication responses. He also emphasized the need to move away from assumptions-based prescriptions towards a personalized approach to prescribing medication. Dr. Fontanella's insights underscored the potential of pharmacogenomics to optimize patient outcomes and revolutionize medication management practices. #MDForLives #Pharmacogenomics #PersonalizedMedicine #GeneticResearch #MedicationManagement #HealthTech #PrecisionMedicine #GeneticVariations #MedicalInnovation #PatientCare #FutureOfMedicine #HealthPodcast #PaidSurveys #HealthcareSurveys

Tackling Rare Diseases with An Arsenal of Real-World Data with OM1, Inc. Historically, rare disease patient registries have been developed by various stakeholders at the local, national or international level — targeting natural history, establishing eligible patient pools for clinical trials, and identifying and tracking meaningful clinical endpoints. With over 7000 rare diseases identified, many of which are chronic and complex, data collection requirements and duration of follow-up have often made these cumbersome and difficult to effectively maintain long-term in such settings. So how do we use the new tools in our arsenal to tackle the challenges that remain in rare diseases? ✅Decreasing time to diagnosis ✅Identifying under-appreciated variation in patient phenotypes ✅Tracking changes in our understanding of the disease over time ✅Increasing the efficiency of genomic testing and other detection modalities  ✅Informing a changing paradigm for risk management Interested in learning more about how OM1 can support rare disease research? Check out these links: Rare Disease Day: 📍https://lnkd.in/ddZ_DXFa Rare Disease + RWD: 📍https://lnkd.in/ehJzUN2U PhenOM ebook: 📍 https://lnkd.in/dA8HrjAN Book a Meeting: 📍 https://lnkd.in/eJcKBAJK #rarediseaseday #raredisease #artificialintelligence #patientrecruitment   

Tackling Rare Diseases with An Arsenal of Real-World Data at OM1, Inc. Historically, rare disease patient registries have been developed by various stakeholders at the local, national or international level — targeting natural history, establishing eligible patient pools for clinical trials, and identifying and tracking meaningful clinical endpoints. With over 7000 rare diseases identified, many of which are chronic and complex, data collection requirements and duration of follow-up have often made these cumbersome and difficult to effectively maintain long-term in such settings. So how do we use the new tools in our arsenal to tackle the challenges that remain in rare diseases? ✅Decreasing time to diagnosis ✅Identifying under-appreciated variation in patient phenotypes ✅Tracking changes in our understanding of the disease over time ✅Increasing the efficiency of genomic testing and other detection modalities  ✅Informing a changing paradigm for risk management Interested in learning more about how OM1 can support rare disease research? Check out these links: PhenOM ebook: 📍 https://lnkd.in/dA8HrjAN Book a Meeting: 📍 https://lnkd.in/eJcKBAJK #RareDisease #ArtificialIntelligence #PatientIdentification #AI

#orthopedics #orthopedicsurgery #fracture #clinical #informatics leads to #healing!

New from Dr Middleton, Dr Wolf and colleagues in @kidneymed Targeting Gut Microbiome With Prebiotic in Patients With CKD: The TarGut-CKD Study https://lnkd.in/eeB6z35v

As we countdown to #RareDiseaseDay we're reminded of why we work every day to provide a solution that enhances research, care, and diagnosis for even the rarest conditions. PhenoTips' complete #GenomicHealthRecord empowers #RareDisease researchers and clinicians with the potential of modern technology, placing #HPO deep phenotyping, #OMIM & #ORDO diagnostic insights, and seamless collaboration at their fingertips. Learn more about Phenotips for #RareDiseases: https://lnkd.in/eVF2PUHi

The advantage of saliva collector: 1️⃣ Non-Invasive and User-Friendly: Say goodbye to needles and invasive procedures. The saliva collector offers a painless and stress-free alternative for sample collection, making it particularly suitable for sensitive populations such as children, the elderly, and individuals with needle phobia. 2️⃣ Convenience and Accessibility: Sample collection can now be done anytime, anywhere, with minimal equipment and expertise required. Whether in a clinical setting or the comfort of one's home, the saliva collector offers unparalleled convenience and accessibility for both researchers and patients. 3️⃣ Versatility: From biomarker research to diagnostics and beyond, saliva has emerged as a rich source of biological information. The saliva collector opens doors to a myriad of applications, including the detection of infectious diseases, monitoring of hormone levels, and genetic analysis. 4️⃣ Reliable and Cost-Effective: With advances in technology, saliva collectors ensure high sample integrity and reproducibility, rivaling traditional sample collection methods. Moreover, the scalability and cost-effectiveness of saliva collection make it an attractive option for large-scale studies and population-wide screenings. #SalivaCollector #BiomedicalResearch #HealthcareInnovation #NonInvasiveSampling #PrecisionMedicine #nodford

🌟 Biotechnology is revolutionizing public health! At Public Trust Solutions, we’re at the forefront of integrating biotech innovations into disease prevention. By leveraging cutting-edge technology, our goal is to create healthier communities across the globe. Here’s how we’re making an impact: • Advanced genetic testing 🧬 • Innovative outbreak simulations 🦠 • Community health outreach 👥 We want to hear from you! How do you think biotechnology can transform public health? Drop your thoughts in the comments below! #PublicHealth #Biotechnology #DiseasePrevention #HealthInnovation #PublicTrustSolutions